Fulcrum Therapeutics Inc (FULC)
7.45
-0.05
(-0.67%)
USD |
NASDAQ |
May 10, 16:00
7.45
0.00 (0.00%)
After-Hours: 20:00
Fulcrum Therapeutics Cash from Investing (Quarterly): 18.35M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 18.35M |
| September 30, 2023 | 19.02M |
| June 30, 2023 | 19.88M |
| March 31, 2023 | -93.94M |
| December 31, 2022 | -36.36M |
| September 30, 2022 | -2.279M |
| June 30, 2022 | 31.40M |
| March 31, 2022 | 19.66M |
| December 31, 2021 | -9.094M |
| September 30, 2021 | -106.64M |
| June 30, 2021 | -26.35M |
| March 31, 2021 | 12.42M |
| Date | Value |
|---|---|
| December 31, 2020 | -14.60M |
| September 30, 2020 | 14.09M |
| June 30, 2020 | -0.226M |
| March 31, 2020 | -56.40M |
| December 31, 2019 | -0.108M |
| September 30, 2019 | -0.214M |
| June 30, 2019 | -0.221M |
| March 31, 2019 | -0.401M |
| December 31, 2018 | -3.466M |
| September 30, 2018 | -0.926M |
| June 30, 2018 | -3.806M |
| March 31, 2018 | -0.783M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-106.64M
Minimum
Sep 2021
31.40M
Maximum
Jun 2022
-11.14M
Average
-0.221M
Median
Jun 2019
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc | 1.732B |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 9.462M |
| iBio Inc | 0.00 |
| Theriva Biologics Inc | -0.056M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -23.16M |
| Cash from Financing (Quarterly) | 0.287M |
| Free Cash Flow | -91.47M |
| Free Cash Flow Per Share (Quarterly) | -0.3755 |
| Free Cash Flow to Equity (Quarterly) | -23.24M |
| Free Cash Flow Yield | -20.03% |